Pricing Log in Create free account

Telesis Bio Inc. (TBIO) vs Vivos Therapeutics, Inc. (VVOS)

Telesis Bio Inc. and Vivos Therapeutics, Inc. are both Medical Devices companies. Telesis Bio Inc. is the larger, with a market value of $5.3M against $4.8M — 1.1× the size. Vivos Therapeutics, Inc. grew revenue faster over the last twelve months: 45.2% against −38.1%. Vivos Therapeutics, Inc. has the higher net margin (−121.8% vs −287.9%) and the lower return on invested capital (−592.7% vs 0.00%). Across the 17 metrics below, Vivos Therapeutics, Inc. leads on 11 and Telesis Bio Inc. on 6.

Valuation

Metric TBIO VVOS Medical Devices median
P/E n/m n/m 23.22
P/S 0.00 0.11 2.34
P/B n/m n/m 2.33
Price to free cash flow n/m n/m 23.72
EV/EBITDA n/m n/m 11.54
EV/Sales 0.10 0.41 2.24
Earnings yield (70,502.50%) (1,461.54%) (10.09%)
Free cash flow yield (33,623.80%) (827.13%) (8.47%)

Profitability

Metric TBIO VVOS Medical Devices median
Gross margin 45.62% 61.89% 56.01%
Operating margin (265.73%) (107.89%) (15.03%)
Net margin (287.90%) (121.79%) (20.40%)
Free cash flow margin (143.25%) (90.97%) (7.24%)
Return on equity 1,013.88% 10,022.05% (15.32%)
Return on assets (73.87%) (101.46%) (19.72%)
Return on invested capital 0.00% (592.70%) (10.33%)

Growth

Metric TBIO VVOS Medical Devices median
Revenue growth (TTM) (38.09%) 45.21% 8.80%
EPS growth (last fiscal year) 0.61% 6.76% 29.03%
Revenue growth, 5-year CAGR 41.76% 5.95% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TBIO VVOS Medical Devices median
Debt to equity (0.23) (2.04) 0.07
Current ratio 1.23 0.21 2.50
Net debt to EBITDA 0.46 (0.37) 0.49

Dividend

Metric TBIO VVOS Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric TBIO VVOS Medical Devices median
Market cap 5.31m 4.80m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack